Richard D. Taylor

8.8k citations

28 papers · 7.0k indexed · 4 hit papers · h-index 18

Molecular Biology top 2%
Organic Chemistry top 0.5%
Computational Theory and Mathematics top 0.1%
Pharmacology top 1%
Materials Chemistry top 10%

Co-authors: Alastair D. G. Lawson Malcolm MacCoss Christopher W. Murray Marcel L. Verdonk Michael J. Hartshorn Jason C. Cole Jonathan W. Essex Philip J. Jewsbury
Topics: Computational Drug Discovery Methods (16 papers)Protein Structure and Dynamics (10 papers)Monoclonal and Polyclonal Antibodies Research (7 papers)
Cited by: Computational Theory and Mathematics Organic Chemistry Molecular Biology
Journals: Chemical Society Reviews Scientific Reports Monthly Notices of the Royal Astronomical Society
Partner nations: United Kingdom United States Belgium

In The Last Decade

Richard D. Taylor

28 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved protein–ligand docking using GOLD

2003 2.4k citations Marcel L. Verdonk, Jason C. Cole et al. Proteins Structure Function and Bioinformatics profile →
Rings in Drugs

2014 2.1k citations Richard D. Taylor, Malcolm MacCoss et al. Journal of Medicinal Chemistry profile →
A review of protein-small molecule docking methods

2002 483 citations Richard D. Taylor, Philip J. Jewsbury et al. Journal of Computer-Aided Molecular Design profile →
Rings in Clinical Trials and Drugs: Present and Future

2022 280 citations Alastair D. G. Lawson, Malcolm MacCoss et al. Journal of Medicinal Chemistry profile →

Peers

Countries citing papers authored by Richard D. Taylor

Since Specialization

Citations

This map shows the geographic impact of Richard D. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Taylor more than expected).

Fields of papers citing papers by Richard D. Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Taylor. The network helps show where Richard D. Taylor may publish in the future.

Co-authorship network of co-authors of Richard D. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Taylor. A scholar is included among the top collaborators of Richard D. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Taylor. Richard D. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design of Novel Series of Antimalarial PMX Inhibitors with Increased Half-Life via Molecular Property Optimization 2023 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Jeffrey Bruffaerts,Luigi Stasi,Bénédicte Lallemand,Á. de Pablo Cárdenas,Richard D. Taylor,Lewis R. Vidler,Lloyd E. King,Jean‐Pierre Valentin,Benoı̂t Laleu,(unknown)	5
2	Higher Affinity Antibodies Bind With Lower Hydration and Flexibility in Large Scale Simulations 2022 ·Frontiers in Immunology ·(unknown),Sebastian Kelm,Xiaofeng Liu,Richard D. Taylor,Terry Baker,Jonathan W. Essex	4
3	Open Binding Pose Metadynamics: An Effective Approach for the Ranking of Protein–Ligand Binding Poses 2022 ·Journal of Chemical Information and Modeling ·(unknown),(unknown),Simone Aureli,Benjamin P. Cossins,Richard D. Taylor,Francesco Luigi Gervasio	17
4	Water Networks in Complexes between Proteins and FDA-Approved Drugs 2022 ·Journal of Chemical Information and Modeling ·(unknown),Hannah E. Bruce Macdonald,Richard D. Taylor,Jonathan W. Essex	8
5	Water molecules at protein–drug interfaces: computational prediction and analysis methods 2021 ·Chemical Society Reviews ·(unknown),Richard D. Taylor,Hannah E. Bruce Macdonald,Jonathan W. Essex	43
6	Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signaling 2017 ·Scientific Reports ·Ralph Adams,Rebecca J. Burnley,Chiara R. Valenzano,Omar Qureshi,C. Kuyler Doyle,Simon Lumb,(unknown),Robert Griffin,David McMillan,Richard D. Taylor,Chris Meier,(unknown),Laura Griffin,U. Wernery,Jörg Kinne,Stephen Rapecki,Terry Baker,Alastair D. G. Lawson,Michael Wright,Anna Ettorre	36
7	Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping 2017 ·Scientific Reports ·Xiaofeng Liu,Richard D. Taylor,Laura Griffin,(unknown),Ralph Adams,Tom Ceska,Jiye Shi,Alastair D. G. Lawson,Terry Baker	30
8	Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery 2016 ·Journal of Medicinal Chemistry ·Richard D. Taylor,Malcolm MacCoss,Alastair D. G. Lawson	53
9	Rings in Drugsbreakdown → 2014 ·Journal of Medicinal Chemistry ·Richard D. Taylor,Malcolm MacCoss,Alastair D. G. Lawson	2051
10	Structure-Based Virtual Screening for Novel Ligands 2013 ·Methods in molecular biology ·William R. Pitt,Mark Calmiano,(unknown),Richard D. Taylor,James P. Turner,Michael A. King	15
11	Comparing protein–ligand docking programs is difficult 2005 ·Proteins Structure Function and Bioinformatics ·Jason C. Cole,Christopher W. Murray,J. Willem M. Nissink,Richard D. Taylor,Robin Taylor,(unknown),(unknown)	275
12	Prediction of binding modes for ligands in the cytochromes P450 and other heme‐containing proteins 2005 ·Proteins Structure Function and Bioinformatics ·Stewart B. Kirton,Christopher W. Murray,Marcel L. Verdonk,Richard D. Taylor	86
13	The parameterization and validation of generalized born models using the pairwise descreening approximation 2004 ·Journal of Computational Chemistry ·Julien Michel,Richard D. Taylor,Jonathan W. Essex	10
14	Virtual Screening Using Protein−Ligand Docking: Avoiding Artificial Enrichment 2004 ·Journal of Chemical Information and Computer Sciences ·Marcel L. Verdonk,Valério Berdini,Michael J. Hartshorn,Wijnand T. M. Mooij,Christopher W. Murray,Richard D. Taylor,Paul Watson	327
15	FDS: Flexible ligand and receptor docking with a continuum solvent model and soft‐core energy function 2003 ·Journal of Computational Chemistry ·Richard D. Taylor,Philip J. Jewsbury,Jonathan W. Essex	63
16	Improved protein–ligand docking using GOLDbreakdown → 2003 ·Proteins Structure Function and Bioinformatics ·Marcel L. Verdonk,Jason C. Cole,Michael J. Hartshorn,Christopher W. Murray,Richard D. Taylor	2421
17	A review of protein-small molecule docking methodsbreakdown → 2002 ·Journal of Computer-Aided Molecular Design ·Richard D. Taylor,Philip J. Jewsbury,Jonathan W. Essex	483
18	Intramuscular triglyceride and muscle insulin sensitivity: Evidence for a relationship in nondiabetic subjects 1996 ·Metabolism ·David I. W. Phillips,Sarah Caddy,Vesna Ilić,Barbara A. Fielding,Keith N. Frayn,A C Borthwick,Richard D. Taylor	318
19	A New β Chain Variant, Hb Tyne [β5(A2)Pro->ser] 1994 ·Hemoglobin ·Jonathan Langdown,D. Williamson,Charles Beresford,I Gibb,Richard D. Taylor,(unknown)	14
20	Capillary column gas chromatography-mass spectrometry for the determination of the fatty acid composition of human adipose tissue 1989 ·Journal of Chromatography B Biomedical Sciences and Applications ·(unknown),(unknown),Richard D. Taylor,K. G. M. M. Alberti,M F Laker	15

About Richard D. Taylor

Richard D. Taylor is a scholar working on Computational Theory and Mathematics, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 28 papers that have together received 7.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (16 papers), Protein Structure and Dynamics (10 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Computational Theory and Mathematics (2.1k citations), Organic Chemistry (3.0k citations) and Molecular Biology (3.4k citations). Richard D. Taylor has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Alastair D. G. Lawson, Malcolm MacCoss, Christopher W. Murray, Marcel L. Verdonk, Michael J. Hartshorn, Jason C. Cole, Jonathan W. Essex, Philip J. Jewsbury, Robin Taylor and J. Willem M. Nissink. Their work appears in journals such as Chemical Society Reviews, Scientific Reports and Monthly Notices of the Royal Astronomical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact